Contact
La Vanguardia devotes an article to innovation, with interviews with several entrepreneurs, among these IRB Barcelona researcher Teresa Tarragó, co-founder of the spin-off Iproteos. Ernest Giralt and Teresa Tarragó set up Iproteos in 2011, thanks to a technology developed in the IRB Barcelona lab headed by Giralt. The company’s endeavours focus on the development of drugs mainly to combat diseases of the central nervous system.
Read the article in La Vanguardia (PDF in Spanish)
Link to La Vanguardia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
